Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Interventional, Two-arm, Parallel-group, Randomized, Double-blinded, Placebo-controlled, Phase IV Trial to Evaluate the Efficacy of Alpha-Lipoic Acid in the Treatment of Symptomatic Diabetic Polyneuropathy in Egypt

NCT05813496 is registered in ClinicalTrials.gov with Eva Pharma as lead sponsor.

NCT NCT05813496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05813496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Interventional, Two-arm, Parallel-group, Randomized, Double-blinded, Placebo-controlled, Phase IV Trial to Evaluate the Efficacy of Alpha-Lipoic Acid in the Treatment of Symptomatic Diabetic Polyneuropathy in Egypt
Lead sponsor
Eva Pharma
Phase
Phase 4
Overall status
Completed
Start date
October 26, 2022
Completion date
December 11, 2024
Enrollment
430 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

polyneuropathy, diabetic